Medical management of perimenopausal menorrhagia: an evidence-based approach

In: Menopause International · 2007 · vol. 13(1) , pp. 14–18 · doi:10.1258/175404507780456782 · PMID:17448262 · W2142152392
review OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This paper reviews evidence-based medical therapies for perimenopausal menorrhagia, highlighting levonorgestrel intrauterine systems as the most effective treatment among options including progestogens, oral contraceptives, tranexamic acid, mefenamic acid, danazol, and GnRH analogues.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

About one-third of women report heavy menstrual bleeding at some time in their lives. Menstrual blood loss increases with age. Menorrhagia is usually defined as heavy but regular menstrual bleeding of over 80 ml/cycle. Complaints of menorrhagia are common. Several medical therapies are suitable for perimenopausal women with either regular or irregular heavy bleeding. The most effective is intrauterine levonorgestrel. Other options are oral progestogens, the combined oral contraceptive pill, tranexamic acid, mefenamic acid, danazol and gonadotrophin-releasing hormone (GnRH) analogues. Systematic reviews and randomized controlled trials are discussed.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T05:19:45.559451+00:00
License: CC0 · commercial use OK